OC459 is a low dose, once-a-day drug with an excellent safety profile demonstrated in over 800 subjects CRTH2 receptor and its role in allergy Company Overview Atopix Therapeutics Limited is a clinical cialis stage biotechnology company developing novel treatments for Th2-mediated eosinophilic asthma. The company is developing a novel class of oral anti-Th2 therapies, called […]